




























In a recent issue of Aging, Dubrovsky et al. [1] describe 
the effects of disruption of the Clock gene on lifespan 
and health in mice.  They report that CLOCK-deficient 
mice have reduced average and maximum lifespan, and 
have increased incidence of dermatitis and cataracts as 
the animals age [1].  Notably, however, targeted 
disruption of the Clock gene does not lead to the same 
constellation of phenotypes as seen in mice with 
disruption of other genes critical for circadian clock 
function (Tables 1 and 2).   In this Review, we summari-
ze and discuss potential reasons for the gene-specific 
effects of circadian clock gene disruption.  Why do these 
mouse models differ?  And, what do these differences tell 
us about the role of the circadian clock in the regulation 
of physiology, healthy aging, and responses to genotoxic 
stress?  Before addressing these questions, we will 
describe the circadian clock mechanism and the circadian 
clock gene hypothesis of cancer/aging.   
 
The circadian clock is based on a transcriptional-
translational feedback loop 
 
Many cell types contain cell-autonomous circadian 
clocks  that   measure  24   hours.   These  clocks  impart  
 
 



























rhythmicity on function in virtually every organ. The 
biological timekeeping mechanism is based on a 
negative feedback loop involving the rhythmic 
production, followed by protracted degradation, of 
protein complexes that shut off their own production.  
The alternation between transcriptional activation and 
transcriptional inhibition occurs with a cycle length of 
approximately 24 hours [for review see 2,3].   In 
mammals, at the core of this mechanism are genes 
called Clock and Bmal1 (also called Mop3 or Arntl) 
(Figure 1). The protein products of these genes, 
CLOCK and BMAL1, are basic helix-loop-helix-PAS 
(bHLH-PAS) domain-containing transcription factors.   
They are dimerization partners of central importance to 
the function of the circadian clock, although NPAS2, 
another bHLH-PAS protein, can substitute for CLOCK 
as partner for BMAL1 in neurons of the 
suprachiasmatic nucleus (SCN) that control locomotor 
activity rhythms [4,5].   Proteins critical for closing the 
negative feedback loop include the products of the Per1 
and Per2 genes, and the Cry1 and Cry2 genes; within 
these gene families there is redundancy of function, 
such that disruption of both Per1 and Per2, or both Cry1 
and Cry2, is necessary to completely disrupt circadian 
rhythmicity [6-9].  Because these mutant lines provide 
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circadian clock in aging and the response to genotoxic 
stress would result.  However, these mutant lines differ 
in their aging-related phenotypes, as well as having 
subtle differences in their circadian clock function.  
 
The circadian clock gene hypotheses of cancer and 
aging, corollaries and caveats 
 
A great deal of experimental effort has addressed the 
role of the circadian clock genes in aging and especially 
in cancer-related phenotypes.  The hypothesis being 
tested is usually that a circadian clock gene functions as 
a tumor suppressor gene, playing a role in retarding 
cancer development (or aging).  More specifically, the 
hypothesis is that “circadian genes are involved in 
(cancer-related) biological pathways such as cell 
proliferation and apoptosis by controlling the expression 
of tumor suppressor genes, cell cycle genes, and genes 
encoding caspases and transcription factors” [10].  The 
basis for this hypothesis is that there are interactions 
between the cell cycle and circadian cycle, and 
dysregulation of the circadian clock is then thought to 
lead to dysregulation of cell cycle control [10].   
 
Corollaries (with emphasis on cancer) are:  
(1) mutations of circadian clock genes will be 
associated with altered rates of cancer;  
(2) circadian “clock gene” and protein expression levels 
will be altered in tumors; 
(3) mutant mice with disrupted circadian clock genes 
will have altered (increased) cancer incidence under 
basal aging conditions, following gamma-irradiation, 
and in cancer-prone models. 
 
Studies in support of this hypothesis are plentiful, as 
reviewed in greater detail below. Several studies 
indicate that circadian clock genes and their products 
contribute to regulation of cell cycle genes, apoptosis, 
and gene expression, and indicate molecular 
mechanisms by which these processes might be 
affected by clock gene products  [11-21] [for recent 
reviews, see 22-33].  Many studies report altered 
(usually decreased) levels of clock gene expression in 
tumors [34-39; but see 40,41].  Conversely, in 
experimental models, overexpression of clock genes in 
tumors or in cancer cell lines reduces tumor growth 
[11, 42-45].  Mice homozygous for disruption of 
circadian clock genes that lead to loss of rhythmicity 
have many phenotypic abnormalities.  Among these 
phenotypes are increases in basal cancer incidence or 
in the incidence of cancer following genotoxic stress 
or in genetically cancer-prone models [46-50; but see 
51].  Similarly, knocking down the expression level of 
circadian clock genes can promote cancer growth [19, 
52-55; but see 56, 57].  In humans, genome-wide 
association studies and more targeted studies have 
identified allelic variants, mutations, and epigenetic 
modifications that are associated with differences in 
risk of cancer [58-70].  Collectively, then, do these 
studies provide strong evidence that the circadian 
clock, and circadian rhythmicity, regulate aging and 
cancer?  Remarkably, no.  While the contribution of 
several circadian clock genes to cancer defense seem 
well-established, the contribution of the circadian 
clock is much less clear.  
 
Functional impact of mutant alleles 
 
In epidemiological studies, the circadian clock gene 
hypothesis of cancer proposes that genetic variations in 
clock genes are likely to be associated with individual 
susceptibility to cancer [62].  A more specific 
formulation of the hypothesis is that “circadian 
disruption may be a novel risk factor and that genetic 
determinants for circadian rhythms may play a role in… 
tumorigenesis” [59], which emphasizes the interaction 
of genetic predisposition based in the circadian clock 
genes with environmental influences (especially shift 
work and light exposure at night, which can disrupt 
diurnal rhythms; see below). Several epidemiological 
studies have been conducted, examining allele 
frequencies for polymorphisms in and around clock 
genes in association with different types of cancer.   
Many positive associations have been reported, both in 
targeted analyses and in genome-wide association 
studies [58-70].   
 
An important factor for interpreting epidemiological 
studies is the observation in mutant mice that null 
alleles of circadian clock genes are usually recessive; 
that is, animals heterozygous for a loss-of-function 
allele have little or no deficit in overt circadian rhythms.  
Furthermore, within several of the circadian gene 
families, there is functional redundancy between closely 
related genes [Reviewed in [2]]. Mutations that lead to 
loss of circadian clock function have global effects on 
systemic physiology and metabolism, endocrine 
function and behavior.  The functional impact of single 
nucleotide polymorphisms (SNP’s) within or near 
circadian clock genes on the maintenance of 
rhythmicity is much less clear.  It is likely that most 
SNPs near circadian genes do not lead to demonstrable 
changes in circadian oscillator function, either centrally 
or peripherally. Circadian clock genes may be 
influencing disease susceptibility due to their 
pleiotropic activities on gene expression or involvement 
in other pathways, rather than through their involvement 
in circadian clock function.  As with GWAS studies in 
most fields, progression from identification of loci to 
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quite difficult.  
 
Gene expression rhythmicity or gene expression 
level? 
 
Microarray studies show that from 5-10% of transcripts 
are expressed with 24-hour rhythmicity.  The specific 
genes that are rhythmic vary from tissue to tissue [17, 
71-82], but key, rate-limiting steps are often rhythmic 
[71,72]. Disrupting critical circadian clock genes not 
only disrupts rhythmicity of target gene expression, but 
it can also have dramatic consequences on the level of 
expression of many target genes [73. 76-77].   
Furthermore, the manner in which the circadian 
feedback loop is disrupted often has differing effects on 
the resulting level of gene expression. So, one might 
expect that disrupting genes on the activational side of 
the transcriptional feedback loop (Clock/Bmal1/Npas2) 




































opposite to the effects seen when disrupting the genes 
whose products form the repressor complex (Pers and 
Crys; in this case the activator complex may act 
unopposed (Figure 1)).  (To use a household analogy, 
in the former case the furnace is broken so no heat is 
produced; in the latter case the thermostat is broken so 
the signal to turn off heat production is not given, and 
the room overheats.  In both cases the system is 
broken, but the effects on steady state room 
temperature are opposite).  An interesting distinction 
to keep in mind when considering phenotypes 
resulting from circadian gene disruption is whether the 
phenotype could be due to loss of rhythmicity of gene 
expression, versus due to the potentially disruption-
specific effects on gene expression level.  In the 
former case, we might expect that all mutations of 
circadian genes leading to loss of rhythmicity would 
have a similar phenotype, while in the latter case we 
can envision how disruption of different circadian 



































































































































Environmental lighting, rhythms and disease 
 
It is also worth pointing out that almost all studies of 
aging-related endpoints in circadian mutant mice have 
been conducted with animals housed in a light-dark 
cycle.  Rhythmic lighting cycles can drive behavioral 
and physiological rhythmicity (to varying extents, 
depending on the genotype and circumstances) even in 
the absence of a functioning circadian clock (e.g., see 
Figure 2C). Thus, many studies are assessing the 
phenotype in the presence of LD- imposed rhythmicity.  
The phenotype of circadian mutant mice may be 
considerably more pronounced if they were to be 
studied after housing in constant dark conditions. 
(Constant light is rarely used as it can disrupt rhythms if 
too bright, and controlling light intensity across a group 
of cages is more difficult than maintaining consistency 
from cage to cage with darkness.)  Two recent studies 
[48, 83] highlight the exacerbation of that can occur 
when circadian mutant mice are housed in constant 
darkness, compared to the same genotype housed in a 
standard light: dark cycle. Thus, circadian mutant mice 
are often studied under conditions that may not allow 
full expression of their genetic deficits.  Nevertheless, 
as both a practical matter related to monitoring of health 
Figure  2.  Locomotor  activity  rhythms  of  circadian 




single  mouse  housed  in  a  cage  with  a  running  wheel.  





shading)  for  ~  2  weeks.  Then,  the  light‐dark  cycle  was 
disabled  and  the  animals  were  recorded  in  constant 
darkness  (DD),  which  allows  expression  of  the  animals’ 
endogenous rhythmicity.  Visual analysis of the “actogram” 
allows easy perception of the  cycle  length (period length, 
















to  DD,  the  animal  expresses  a  “free‐running”  rhythm  that
gradually decreases in amplitude until arrhythmicity is reached.
Mice  homozygous  for  mutation  of  Per1  or  Per2  have  this
phenotype  (although  in  some  studies  these  lines  maintain
rhythmicity  and  resemble  Panel  A).  Clock
￿19/￿19  mutant  mice
initially  have  long‐period  (~  28  hr)  rhythmicity  and  become
arrhythmic  within  ~  10  days  in  constant  darkness.  (C)  The
actogram in Panel C is typical of an animal with complete loss of
circadian  function.   Note  that  the  mouse  appears  to  have
rhythmic behavior when exposed to a light‐dark cycle, due to
suppression  of  wheel‐running  activity  by  ambient  light.
Following discontinuation of the light‐dark cycle, however, the
endogenous pattern (or lack there‐of) becomes apparent.  In this
case,  the  animal  immediately  loses  circa‐24‐hour  rhythmicity.
Despite loss of circadian rhythmicity, the animal still has periods
of activity and rest, just now these intervals do not have the
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disease, studying mutant animals in a lighting cycle is 
appropriate.   
 
Humans, generally, do not reside in constant darkness.  
Remarkably, however, several studies on cancer 
incidence among blind individuals reveal a reduced risk 
[84-90].  Cancer risk is lower when blindness is defined 
in the strictest sense (those with no capacity for light 
photoreception), even relative to those that are blind 
with light perception [80].  Such studies were motivated 
by the observation that exposure to light at night during 
shift work leads to circadian disruption and also 
significantly increases the risk of cancer  [86, 87, 89]. 
Indeed, disrupted circadian rhythmicity caused by light 
exposure at night has been proposed to underly the 
increasing prevalence of breast and prostate cancers in 
industrialized nations.  The International Agency for 
Research on Cancer (IARC) recently concluded that 
“shift-work that involves circadian disruption is 
probably carcinogenic to humans” based on “limited 
evidence in humans” and “sufficient evidence in 
experimental animals for the carcinogenicity of light 
during the daily dark period” [91]. Whether these 
effects are related to nocturnal suppression of melatonin 
production, as advocated by some, remains to be 
established; melatonin has anticancer activity in some 
circumstances [92].   It has been argued that light 
exposure at night is a predictor of adverse health 
outcomes, rather than a cause [93]. 
 
Several recent studies suggest that the process of 
repeatedly resetting one’s clock is a stressor with 
adverse effects on health. Repeated exposure to shifts of 
the light-dark cycle (chronic jet lag) reduces lifespan in 
aged mice [94], alters the immune response to 
lipopolysacchiride challenge in young mice [95], 
accelerates liver carcinogenesis [96-98], and increases 
susceptibility to gastrointestinal damage by dextran 
sulfate [99].  Notably, some of these studies were 
conducted in strains of mice genetically incapable of 
producing melatonin [100], so shift-induced disruption 
of the (nonexistent) melatonin rhythm cannot be the 
mechanism underlying the adverse response. In other 
studies, lines of hamsters that differ in their free-
running cycle length were found to differ in the 
development of cardiac and renal pathologies; animals 
housed in a light-dark cycle that did not match their 
endogenous cycle length had to undergo re-setting of 
their clock on a daily basis to maintain synchrony to the 
lighting cycle [101, 102].  Remarkably, in the hamster 
studies, each line did better when the lighting cycle 
matched its endogenous cycle length, and poorly 
(relative to the other line) when there is a mismatch. 
These animal studies suggest that environmental 
disruption of circadian rhythms has a significant 
adverse effect on health, including carcinogenesis and 
immune function. Circadian misalignment can also 
affect metabolic function in humans [103] with 
potential consequences on antioxidant defenses. Thus, 
there are important consequences of circadian rhythm 




The version of the circadian clock gene hypothesis 
being tested can vary greatly between studies, and 
authors are rarely explicit in articulating the version 
being tested, or its implications.  Two extreme cases can 
make this point.  Lee et al., [48] recently proposed that 
the central circadian clock in the suprachiasmatic 
nucleus of the hypothalamus coordinates the activity of 
peripheral clocks via the sympathetic nervous system, 
and in so doing optimizes anticancer mechanisms 
within peripheral cells.  Their data suggest that any of a 
number of genetic lesions leading to loss of rhythmicity 
promote tumorigenesis, e.g., that the circadian clock 
reduces cancer risk through systemic mechanisms. 
Furthermore, as noted above, in this study maintaining 
animals in light-dark cycles masked the cancer 
phenotype [48].  At the other extreme are data that 
indicate that altering levels of clock gene expression 
affects proliferation in vitro; these effects cannot be 
related to systemic physiological rhythmicity, yet could 
still involve cellular rhythmicity (which persists in 
vitro; 104,105].  Data from both types of studies are 
relevant to the circadian-aging-cancer continuum, but 
these studies implicate different mechanisms and 
require different interpretations.  Questions relevant to 
studies of circadian clock genes and cancer include:  
-  Is behavioral rhythmicity affected by the 
genetic lesion?   
-  Is the circadian clock broken in an “on” or 
“off” state? 
-  What impact does this gene have on expression 
of other genes and processes, and are these necessarily 
related to rhythmicity? 
  
Circadian clock disruption and aging-related 
phenotypes 
 
Do the effects of circadian clock gene disruption on 
aging-related phenotypes make sense with the 
expectation that all mutations leading to loss of 
circadian function will have a common phenotype?   Or 
with the competing alternative, that mutations affecting 
circadian clock function will have effects that make 
sense based on where the gene falls within the circadian 
feedback loop?   The answer, unfortunately, is no.   
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loop: Per and Cry 
 
Both Per1 and Per2 have been described as tumor 
suppressor genes [10, 27]. PER2-deficient mice are 
more susceptible to genetic or radiation-induced cancer 
[46-48], Per1 or Per2 over-expression reduces tumor 
growth in vivo and promotes apoptosis in vitro [42-45], 
while PER down-regulation promotes cancer cell 
growth [46-48, 52-54 (but see 56, 57)].   
Downregulation of Per1 and Per2 gene expression has 
been reported in human tumors [11, 27, 28, 34-39 (but 
see 40, 41)].  These studies identify molecular links 
between PERIOD protein expression and genes known 
to be involved in apoptosis and cell cycle regulation. 
These studies might suggest a tumor suppressor role for 
all proteins that are part of the circadian negative 
feedback loop.  Contrary to this idea, however, is the 
finding that p53-deficient mice lacking both CRY1 and 
CRY2 proteins are actually resistant to cancer and have 
increased lifespan, relative to p53-deficient mice, and 
CRY1/CRY2-deficiency promoted apoptosis following 
UV-irradiation [23, 51 (but see 48)].  Thus, 
paradoxically, CRY deficiency and over-expression of 
PERs are functionally similar, in suppressing tumor 
growth.  One interpretation for the difference between 
PERs and CRYs is that the effects of disrupting 
circadian genes in aging are a complex combination of 
the contribution of these genes to the circadian clock, 
along with their role in other cellular processes and 
pathways [1].  These results, collectively, suggest that 
there is more going on with circadian mutant lines than 
“simple” rhythm disruption. 
 
A recent study by Lee et al. [48] examined several 
mutant mouse models of circadian disruption, and found 
that virtually all lines of mice examined (including 
Per2Brdm1 mutants, Cry1-Cry2 double-knockout, 
Clock
Δ19/Δ19, and Bmal1
-/-, mice) had enhanced tumori-
genesis under basal and irradiated conditions.  Remarkab-
ly, Bmal1 heterozygotes and Cry1-deficient mice, both of 
which maintain circadian rhythms even in constant 
darkness, were also more cancer-prone than the controls. 
The increased cancer incidence in lines that maintain 
circadian rhythms seems inconsistent with the conclusion 
that disruption of rhythmic sympathetic outflow underlies 
the increased tumor development.  Furthermore, coat 
color variation evident in their Figure 1b suggests 
differences in genetic background between groups.   
 
Disrupting the positive limb of the circadian feedback 
loop: Bmal1 and Clock 
 
The suggestion that there is more going on regarding 
the clock/aging/cancer interface is reinforced by the 
results of studies examining genes on the positive side 
of the transcriptional feedback loop.   
 




Δ19/Δ19).  The aging and 
cancer-related phenotypes of these mouse models are 
not consistent (Table 1), nor are they consistently 
“opposite” the effects of disrupting the molecular 
components of the negative feedback loop (Table 2). 
 
The most severe phenotype is observed in BMAL1-
deficient mice.  BMAL1 is the only gene which, when 
disrupted, leads to a complete loss of behavioral 
circadian rhythmicity [106].  Additional phenotypes of 
BMAL1-deficient mice include greatly reduced 
lifespan, sarcopenia, age-dependent weight loss, 
reduced organ weight, cataracts, ectopic calcification of 
tendons and cartilage, and male and female sterility [50, 
107-112]. Restoration of BMAL1 expression in the 
brain of BMAL1-deficient mice rescued circadian 
behavioral rhythms but did not prevent ectopic 
calcification [112].  Rescuing BMAL1 expression in 
muscle did not restore behavioral rhythmicity or prevent 
ectopic calcification, but did prevent weight loss [112].  
These results clearly reveal that the multiple phenotypes 
of BMAL-deficient mice cannot all be attributed to the 
loss of circadian rhythmicity.  Instead, BMAL1 
expression affects organ function in a site-specific 
manner, although some systemic influences also are 
likely [113-115]. 
 
While CLOCK-deficient mice have reduced lifespan 
[1], CLOCK-deficient mice do not have age-dependent 
reductions in body weight or reduced relative organ 
weights [1] or ectopic calcification [116], and are fertile 
(although female reproductive performance is reduced; 
our unpublished results).  In these animals, behavioral 
rhythms are preserved, while peripheral tissues have 
only systemically-driven rhythms, indicating that 
peripheral circadian oscillators require CLOCK [117, 
118]. 
 
CLOCK-deficient mice also appear to differ, 
phenotypically, from Clock
Δ19/Δ19 mutant mice, which 
have an intronic splice site point mutation in the Clock 
gene that leads to exclusion of exon 19 from the 
transcript.  This mutant CLOCK protein (CLOCKΔ19) 
is devoid of transcriptional activity but can bind to 
BMAL1; from biochemical and genetic evidence, the 
mutant protein appears to function as a dominant 
negative [4, 5, 119, 120].  Clock
Δ19/Δ19mutant mice have 
a modest aging/cancer phenotype [49; Table 1].   
Lifespan under routine conditions is unaffected 
[Antoch, unpublished data, cited in [49]].  Radiation-
   
www.impactaging.com                   484                                              AGING, May    2011, Vol.3 No.5induced body weight loss, organ weight loss, and 
lifespan shortening are more pronounced in female 
Clock
Δ19/Δ19mutant animals, relative to wild-type 
controls.  In contrast, male Clock
Δ19/Δ19mutant mice do 
not differ from controls in lifespan after irradiation 
(although they did have greater body weight loss than 
controls after irradiation) [49].  Female Clock
Δ19/Δ19 
mutant mice have reduced fecundity and are prone to 
dystocia, but remain fertile [121-122], in contrast to the 













































[106, 109, 110] and in Clock
-/-; Npas
2m/m  double-mutant 
[unpublished data]. 
 
With respect to aging phenotypes in the absence of 
irradiation, the mutant lines can be ordered in decreasing 
severity as follows: Bmal1
-/- >> Clock
-/- >  and 
Clock
Δ19/Δ19.  It will be of considerable interest to see if the 
radiation response of Clock
-/- mice is similarly intermediate 
between these other two mouse lines with disruption of 

























































         
Rhythmic in DD?  Varies [123,141-
144] 
Yes [4, 117]  Yes [4, 145]  No [4]  No [106] 
Period length  Long [~28 hr] to AR  Slightly shorter   Slightly shorter  N/A – Arrhythmic  N/A – Arrhythmic 
Ex vivo Rhythms:           
SCN slice   Arrhythmic [124]  Rhythmic [4, 118]  Rhythmic [118]  Arrhythmic [118]  Arrhythmic [115, 
124; but see 147] 
Peripheral tissues  Arrhythmic [115, 
124] 
Arrhythmic [118]  Rhythmic [118]  Arrhythmic [118]  Arrhythmic [115, 
147] 
Aging Phenotypes           
Lifespan Reduced  (Female) 
Normal (Male) [49] 
Reduced (Both) [1]  Seems OK (Both) [our 
unpublished] 
Reduced (Both) [116]  Reduced (Both) 
[50, 107, 111] 
Body weight  Increased [148]  Normal [1]  N.D.   Reduced [our 
unpublished] 
Reduced [50] 
Organ weights  Normal [148]  Normal [1]  N.D.  N.D.  Most Reduced [50] 
Cataract incidence  N.D.  Increased [1]  N.D.  N.D.  Increased [50] 





No [116]  No [116]  Yes [116]  Yes [108, 112] 
Reproduction Modest  decrease 
[121, 122, 150-153] 
Modest decrease 
[our unpublished] 




Sterile [109, 110] 
Tumor incidence  Normal [49]  N.D.  N.D.  N.D.  N.D. 
Response to 
Irradiation  
         
Lifespan Reduced  (Female) 
Normal (Male) [49] 
N.D. N.D.  N.D.  N.D. 
Body weight  Reduced (Both) [49]  N.D.  N.D.  N.D.  N.D. 
Organ weights  Some Reduced [F]; 
Normal (Male) [49] 
N.D. N.D.  N.D.  N.D. 
Cataract incidence  Increased (Both) 
[49] 
N.D. N.D.  N.D.  N.D. 
Dermatitis N.D.  N.D. N.D.  N.D.  N.D. 
Tumor incidence  Normal [49]  N.D.  N.D.  N.D.  N.D. 
 
   

























































































































Circadian behavior:             
Rhythmic in DD?  Yes [7,   Yes [7, 8]  No [7, 8]  Varies [6, 9, 
154] 
Varies [6, 9, 
156] 
No [6, 9] 
Period length  Shorter  Longer  N/A – 
Arrhythmic 
Short or Normal  Short to Normal  N/A – 
Arrhythmic 
Ex vivo Rhythms:             
SCN slice  
 


















Varies [158]  N.D. 
Aging parameters:             
Lifespan  N.D.   N.D.   N.D.   N.D.   Decreased   N.D.  








Organ weights  N.D.   N.D.   N.D.  N.D.  N.D.  N.D. 
Cataract incidence  N.D.   N.D.   N.D.  N.D.  N.D.  N.D. 
Dermatitis  Increased [48]  N.D.   Increased [48]  N.D.  Normal [48]  Normal [48] 
Ectopic  calcification  No No  No No  No  No 
Bone mass  N.D.  Increased 
[162] 





























Tumor incidence  Increased [48]  N.D.  Normal  [23] 
Increased [48] 






           
Lifespan N.D.  N.D.  Normal  [23] 
Reduced [48] 
N.D. Reduced  [46, 
48] 
Reduced [48] 
Body weight  N.D.   N.D.   N.D.  N.D.  N.D.  N.D. 
Organ weights  N.D.   N.D.   N.D.  N.D.  N.D.  N.D. 
Cataract incidence  N.D.   N.D.   N.D.  N.D.  N.D.  N.D. 
Dermatitis Small  Increase 
[48] 
N.D.  Increased [48]  N.D.  Normal [48]  Increased [48] 





Cancer-prone model      p53
-/-    APCmin/+   
Cancer incidence  N.D.  N.D. Decreased  [51]  N.D.  Increased  [47]  N.D. 
Lifespan  N.D.  N.D.  Increased  [51]  N.D.  Decreased [47]  N.D. 
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Δ19/Δ19 mutant mice 
do not appear to be as severely affected as the CLOCK-
deficient mice with respect to lifespan. Clock
Δ19/Δ19 
mutant mice on the C57BL/6J background lose 
locomotor activity rhythmicity when housed in constant 
darkness [120, 123], while Clock
-/- mice maintain 
behavioral rhythmicity through the redundant action of 
NPAS2 in the SCN [4, 5, 117].   Tissues explants and 




-/-) lose rhythmicity, while 
tissues from wild-type mice maintain rhythms in vitro 
[118, 124, 125].  If disruption of circadian oscillations 
leads to acceleration of aging through disruption of the 
synchronization of metabolic processes [126], one 
might expect that all three lines of mice, with equally 
“incompetent” peripheral oscillators, would have equal 
phenotypes.  They do not.  Of these lines, the Clock
-/- 
mice appear to have the best circadian clock function: 
they can maintain behavioral rhythmicity in constant 
darkness, while the other lines cannot (Figure 2).  While 
many holes remain to be filled in Tables 1 and 2, from 
these studies it appears there is not a good correlation 
between the extent of circadian rhythm disruption and 




What does the future hold for studies of the role of 
circadian clock genes in aging, response to genotoxic 
stress, and cancer?  Most obviously, filling in the gaps 
in Tables 1 and 2 is needed.  How are the acute 
response to radiation and radiation-induced morbidity, 
cancer incidence, and mortality influenced by the 
absence of CLOCK?  What are the causes of premature 
death in CLOCK-deficient mice?  A striking 
preliminary conclusion from the studies discussed here 
is that lifespan and cancer incidence of circadian mutant 
lines under baseline conditions appear to be poorly 
predictive of each other or of responses to genotoxic 
stress and irradiation [22, 33, 49, 50]. 
 
Another line of investigation is to understand the 
molecular mechanisms underlying the age-related 
pathologies in CLOCK-deficient mice identified by 
Dubrovsky et al [1].  What does a higher incidence and 
earlier onset of dermatitis in CLOCK-deficient mice 
mean?  Differences in aggression and interactions 
between cage-mates or in grooming could contribute 
[1], but in addition, the accelerated, age-dependent 
incidence of dermatitis in CLOCK-deficient mice could 
be due to loss of an important, local action of the 
CLOCK:BMAL1 dimer and/or circadian rhythms of 
gene expression.  Fibroblasts, including human dermal 
fibroblasts, have tissue-autonomous molecular circadian 
rhythms [124, 125, 128-132]. Rhythmic clock gene 
expression in skin is disrupted in CRY-deficient or 
SCN-lesioned mice [133].  Hair follicle synchrony (on a 
~ 3-week cycle length) is altered in CLOCKΔ19 and 
Bmal1
-/- mice [134, 135], further indicating a role for 
circadian clock function in skin.  Thus, disruption of 
circadian clock genes likely disrupts skin physiology by 
local actions.  Alternatively, systemic hormonal, 
metabolic or nutritional factors may influence dermal 
integrity.  Histological examination and assessment of 
constituent cell populations is necessary to relate the 
observation of increased dermatitis incidence in 
CLOCK-deficient mice to epithelial, mast, and dendritic 
cells, sebaceous glands and hair follicles.  
 
Similarly, what does the higher incidence of cataracts in 
CLOCK-deficient mice mean?  Cataracts are often 
taken as an indication of excessive reactive oxygen 
species (ROS) and oxidative stress, and indeed, in 
BMAL1-deficient mice, cataracts are delayed by 
treatment with an antioxidant [107]. Does the increased 
age-dependent incidence of cataracts in CLOCK-
deficient mice reflect whole-body ROS status, or local 
events such as oxygen tension and ion transport in the 
lens epithelia?  In future studies, it may be possible to 
distinguish systemic, metabolic influences from local 
effects by local manipulation of these genes, using 
conditional alleles of these genes (in which critical 
exons are flanked by loxP sites) and tissue-specific 
drivers for Cre recombinase.  Tissue-specific gene 
disruption is beginning to be employed in studies of 
circadian rhythms [78, 82, 114, 115, 117].   
 
When discussing circadian rhythms and oxidative 
stress, melatonin may come to mind.  As noted above, 
melatonin is produced in a circadian rhythm, with levels 
elevated at night, and the hormone is widely 
investigated with respect to its antioxidant properties 
following administration at pharmacological levels 
[136, 137].  The role of endogenous melatonin in 
antioxidant defense is unclear.  In the present context, 
however, it is clear that melatonin can play no role: 
C57Bl/6J mice do not produce pineal melatonin [100]. 
 
Another interesting area for study will to be to 
determine the extent to which NPAS2 substitutes for 
CLOCK, mitigating the impact of CLOCK deficiency 
(relative to the more profound effects of BMAL1-
deficiency). In the SCN, NPAS2 maintains circadian 
rhythmicity in the absence of CLOCK [4].  In contrast, 
peripheral tissues are unable to maintain rhythmicity in 
the absence of CLOCK [111, 138, but see 139].  Mice 
lacking both CLOCK and NPAS2 have a profound 
phenotype, appearing very similar to mice lacking 
BMAL1 with respect to age-dependent weight loss, 
   
www.impactaging.com                  487                                              AGING, May   2011, Vol.3 No.5arthropathy, male and female sterility, and premature 
death [Table 1; our laboratory’s unpublished data].  The 
very profound accelerated aging phenotype of these 
double-knockout mice, especially when compared to 
mice lacking CLOCK alone, suggests an important, 
redundant contribution of NPAS2—but where?  In 
CLOCK-deficient mice, pathologies may be restricted 
to those tissues that have naturally low levels of NPAS2 
expression, so in these tissues there is a breakdown of 
redundancy.  Alternatively, the loss of systemic 
rhythmicity may interact in important ways.  An 
exciting prospect is that the conditional (floxed) alleles 
of Clock (in an NPAS2-deficient background) or 
conditional alleles of Bmal1 will allow identification of 
sites and mechanisms of action of premature 
spontaneous aging and of accelerated aging induced by 
genotoxic stress.  Furthermore, the availability of mouse 
lines in which expression of CLOCK or BMAL1 can be 
induced with anatomical and temporal control [112, 
140] allow complementary genetic manipulations to 




While the studies conducted to date do not, in our 
opinion, generate a clear conclusion about the 
contribution of circadian rhythmicity to normal 
aging, several circadian clock genes are clearly 
important in regulating lifespan, cancer susceptibility 
and the cell cycle.  Further studies involving 
manipulation of circadian clock genes, and 
manipulating the environmental housing conditions in 
which animals are studied, have much to offer in the 
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